acetylleucyl-leucyl-norleucinal has been researched along with phenyl acetate in 1 studies
| Studies (acetylleucyl-leucyl-norleucinal) | Trials (acetylleucyl-leucyl-norleucinal) | Recent Studies (post-2010) (acetylleucyl-leucyl-norleucinal) | Studies (phenyl acetate) | Trials (phenyl acetate) | Recent Studies (post-2010) (phenyl acetate) |
|---|---|---|---|---|---|
| 321 | 0 | 53 | 41,232 | 1,558 | 8,330 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimoto, Y; Fukase, H; Higashi, Y; Itabe, H; Mori, M; Takano, T | 1 |
1 other study(ies) available for acetylleucyl-leucyl-norleucinal and phenyl acetate
| Article | Year |
|---|---|
Transmembrane lipid transfer is crucial for providing neutral lipids during very low density lipoprotein assembly in endoplasmic reticulum.
Topics: Acetates; Albumins; Apolipoproteins B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Calcium Channels; Cell Membrane; Cholesterol; Culture Media, Conditioned; Cysteine Proteinase Inhibitors; Cytosol; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Humans; Leupeptins; Lipid Metabolism; Lipoproteins, VLDL; Microsomes; Time Factors; Triglycerides; Tumor Cells, Cultured; Verapamil | 2003 |